Back
Also listed as
IPSEF
OTC
Day Range
$43.09
$43.23
52-Week Range
$25.11
$49.45
Volume
1
50D / 200D Avg
$42.78
/
$35.78
Prev Close
$44.63
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 133.5 | 0.4 |
| P/B | 13.2 | 2.9 |
| ROE % | 10.0 | 3.8 |
| Net Margin % | 12.1 | 3.9 |
| Rev Growth 5Y % | 6.5 | 10.0 |
| D/E | 0.2 | 0.2 |
Key Takeaways
Revenue grew 6.46% annually over 5 years — modest growth
Earnings grew 23.43% over the past year
ROE of 10.03% — decent returns on equity
Debt/Equity of 0.24 — conservative balance sheet
Generating 992.33M in free cash flow
P/E of 133.45 — premium valuation
Growth
Revenue Growth (5Y)
6.46%
Revenue (1Y)-1.22%
Earnings (1Y)23.43%
FCF Growth (3Y)20.54%
Quality
Return on Equity
10.03%
ROIC9.98%
Net Margin12.09%
Op. Margin20.30%
Safety
Debt / Equity
0.24
Current Ratio1.96
Interest Coverage20.67
Valuation
P/E Ratio
133.45
P/B Ratio13.15
EV/EBITDA78.83
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1.22% | Revenue Growth (3Y) | 3.34% |
| Earnings Growth (1Y) | 23.43% | Earnings Growth (3Y) | -18.60% |
| Revenue Growth (5Y) | 6.46% | Earnings Growth (5Y) | -9.86% |
| Profitability | |||
| Revenue (TTM) | 3.53B | Net Income (TTM) | 426.96M |
| ROE | 10.03% | ROA | 6.16% |
| Gross Margin | 70.58% | Operating Margin | 20.30% |
| Net Margin | 12.09% | Free Cash Flow (TTM) | 992.33M |
| ROIC | 9.98% | FCF Growth (3Y) | 20.54% |
| Safety | |||
| Debt / Equity | 0.24 | Current Ratio | 1.96 |
| Interest Coverage | 20.67 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 133.45 | P/B Ratio | 13.15 |
| P/S Ratio | 16.14 | PEG Ratio | 1.09 |
| EV/EBITDA | 78.83 | Dividend Yield | 0.01% |
| Market Cap | 56.98B | Enterprise Value | 56.51B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.53B | 3.57B | 3.31B | 3.16B | 2.75B |
| Net Income | 426.96M | 345.90M | 644.40M | 648.60M | 646.60M |
| EPS (Diluted) | 1.28 | 1.04 | 1.85 | 1.79 | 1.89 |
| Gross Profit | 2.49B | 2.96B | 2.74B | 2.63B | 2.31B |
| Operating Income | 716.85M | 496.70M | 816.00M | 729.90M | 824.70M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 6.93B | 6.44B | 6.32B | 5.61B | 5.01B |
| Total Liabilities | 2.60B | 2.26B | 2.50B | 2.27B | 2.25B |
| Shareholders' Equity | 4.33B | 4.18B | 3.83B | 3.34B | 2.74B |
| Total Debt | 1.05B | 426.80M | 373.50M | 771.60M | 693.10M |
| Cash & Equivalents | 1.52B | 678.10M | 528.40M | 1.17B | 814.70M |
| Current Assets | 2.82B | 2.02B | 1.90B | 2.40B | 1.95B |
| Current Liabilities | 1.44B | 1.51B | 1.63B | 1.34B | 1.23B |